Literature DB >> 11782983

Novel mental retardation-epilepsy syndrome linked to Xp21.1-p11.4.

Peter Hedera1, David Alvarado, Ahmad Beydoun, John K Fink.   

Abstract

We evaluated a kindred with X-linked mental retardation and epilepsy. Seven affected males with mild to moderate mental retardation developed seizures (primarily generalized, tonic-clonic, and atonic) that began on average at 6.8 months of age (range, 4 to 14 months). These patients did not have a history of infantile spasms. There were no dysmorphic features. Other than mental retardation, the neurological examination was unremarkable, with exception of 2 affected subjects who had mild generalized rigidity and ataxia. We identified tight linkage to a group of markers on Xp21.1-p11.4. A maximum two-point LOD score of +3.83 at straight theta = 0 was obtained for markers DXS8090, DXS1069, DXS8102, and DXS8085. This locus spans 7.7cM between DXS1049 and DXS8054 and does not overlap the locus for X-linked West syndrome. The tetraspanin gene, implicated in nonspecific mental retardation, is mapped to this region. We sequenced the tetraspanin coding sequence in subjects with X-linked mental retardation and epilepsy and did not identify disease-specific mutations. The syndrome we describe, designated X-linked mental retardation and epilepsy, is clinically and genetically distinct from X-linked West syndrome and other X-linked mental retardation-epilepsy syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782983     DOI: 10.1002/ana.10051

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Seizures and X-linked intellectual disability.

Authors:  Roger E Stevenson; Kenton R Holden; R Curtis Rogers; Charles E Schwartz
Journal:  Eur J Med Genet       Date:  2012-02-08       Impact factor: 2.708

Review 2.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

3.  ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration.

Authors:  Takuo Hirose; Alfredo Cabrera-Socorro; David Chitayat; Thomas Lemonnier; Olivier Féraud; Carmen Cifuentes-Diaz; Nicolas Gervasi; Cedric Mombereau; Tanay Ghosh; Loredana Stoica; Jeanne d'Arc Al Bacha; Hiroshi Yamada; Marcel A Lauterbach; Marc Guillon; Kiriko Kaneko; Joy W Norris; Komudi Siriwardena; Susan Blasér; Jérémie Teillon; Roberto Mendoza-Londono; Marion Russeau; Julien Hadoux; Sadayoshi Ito; Pierre Corvol; Maria G Matheus; Kenton R Holden; Kohji Takei; Valentina Emiliani; Annelise Bennaceur-Griscelli; Charles E Schwartz; Genevieve Nguyen; Matthias Groszer
Journal:  J Clin Invest       Date:  2019-04-15       Impact factor: 14.808

Review 4.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

5.  Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

Authors:  Olena Korvatska; Nicholas S Strand; Jason D Berndt; Tim Strovas; Dong-Hui Chen; James B Leverenz; Konstantin Kiianitsa; Ignacio F Mata; Emre Karakoc; J Lynne Greenup; Emily Bonkowski; Joseph Chuang; Randall T Moon; Evan E Eichler; Deborah A Nickerson; Cyrus P Zabetian; Brian C Kraemer; Thomas D Bird; Wendy H Raskind
Journal:  Hum Mol Genet       Date:  2013-04-16       Impact factor: 6.150

Review 6.  Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.

Authors:  Daniel J Colacurcio; Anna Pensalfini; Ying Jiang; Ralph A Nixon
Journal:  Free Radic Biol Med       Date:  2017-10-06       Impact factor: 7.376

7.  Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration.

Authors:  Aline Dubos; Anna Castells-Nobau; Hamid Meziane; Merel A W Oortveld; Xander Houbaert; Giovanni Iacono; Christelle Martin; Christophe Mittelhaeuser; Valérie Lalanne; Jamie M Kramer; Anuradha Bhukel; Christine Quentin; Jan Slabbert; Patrik Verstreken; Stefan J Sigrist; Nadia Messaddeq; Marie-Christine Birling; Mohammed Selloum; Henk G Stunnenberg; Yann Humeau; Annette Schenck; Yann Herault
Journal:  Hum Mol Genet       Date:  2015-09-16       Impact factor: 6.150

8.  TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation.

Authors:  Christiane Christophe-Hobertus; Frank Kooy; Jozef Gecz; Marc J Abramowicz; Elke Holinski-Feder; Charles Schwartz; Daniel Christophe
Journal:  BMC Med Genet       Date:  2004-09-02       Impact factor: 2.103

9.  Essential role of ATP6AP2 enrichment in caveolae/lipid raft microdomains for the induction of neuronal differentiation of stem cells.

Authors:  Nehman Makdissy; Katia Haddad; Jeanne D'arc AlBacha; Diana Chaker; Bassel Ismail; Albert Azar; Ghada Oreibi; David Ayoub; Ibrahim Achkar; Didier Quilliot; Ziad Fajloun
Journal:  Stem Cell Res Ther       Date:  2018-05-11       Impact factor: 6.832

10.  Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Authors:  Fresia Pareja; Alissa H Brandes; Thais Basili; Pier Selenica; Felipe C Geyer; Dan Fan; Arnaud Da Cruz Paula; Rahul Kumar; David N Brown; Rodrigo Gularte-Mérida; Barbara Alemar; Rui Bi; Raymond S Lim; Ino de Bruijn; Sho Fujisawa; Rui Gardner; Elvin Feng; Anqi Li; Edaise M da Silva; John R Lozada; Pedro Blecua; Leona Cohen-Gould; Achim A Jungbluth; Emad A Rakha; Ian O Ellis; Maria I A Edelweiss; Juan Palazzo; Larry Norton; Travis Hollmann; Marcia Edelweiss; Brian P Rubin; Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Commun       Date:  2018-08-30       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.